A processed pseudogene codes for a new antigen recognized by a CD8+ T cell clone on melanoma

Journal of Experimental Medicine

Volumn 191, Issue 9, 2000, Pages 1617-1623

  Moreau Aubry, Agnès ^a   Le Guiner, Soizic ^a   Labarrière, Nathalie ^a   Gesnel, Marie Claude ^a   Jotereau, Francine ^a   Breathnach, Richard ^a  

^a INSERM   (France)

Author keywords

CTL; Epitope; Peptide; Processing; Tumor immunity

Indexed keywords

CD8 ANTIGEN; COMPLEMENTARY DNA; HLA B ANTIGEN; HOMEODOMAIN PROTEIN; MELANOMA ANTIGEN; MESSENGER RNA; VALINE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN COS1; CODON; CONTROLLED STUDY; DNA LIBRARY; DNA TRANSFECTION; GENE SEQUENCE; GENOME; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MELANOMA CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PSEUDOGENE; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; CODON, TERMINATOR; CYTOTOXICITY, IMMUNOLOGIC; GENE LIBRARY; HLA-B ANTIGENS; HOMEODOMAIN PROTEINS; HUMANS; LYMPHOCYTE ACTIVATION; MELANOMA; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PSEUDOGENES; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 0034192348     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.9.1617     Document Type: Article

References (28)

1. Van den Eynde, B.J., and P. Van der Bruggen. 1997. T cell defined tumor antigens. Curr. Opin. Immunol. 9:684-693.
2. Rosenberg, S.A., J.R. Yannelli, J.C. Yang, S.L. Topalian, D.J. Schwartzentruber, J.S. Weber, D.R. Parkinson, C.A. Seipp, J.H. Einhorn, and D.E. White. 1994. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. J. Natl. Cancer Inst. 865:1159-1166.
3. Marchand, M., P. Weynants, E. Rankin, F. Arienti, F. Belli, G. Parmiani, N. Cascinelli, A. Bourlond, R. Vanwijck, Y. Humblet, et al. 1995. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer. 63:883-885.
4. Rosenberg, S.A., J.C. Yang, D.J. Schwartzentruber, P. Hwu, F.M. Marincola, S.L. Topalian, N.P. Restifo, M.E. Dudley, S.L. Schwarz, P.J. Spiess, et al. 1998. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4:321-327.
5. Nestle, F.O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4:328-332.
6. Mayrand, S.M., and W.R. Green. 1998. Non-traditionally derived CTL epitopes: exceptions that prove the rules? Immunol. Today. 19:551-556.
7. Guilloux, Y., S. Lucas, V.G. Brichard, P.A. Van, C. Viret, E. De Plaen, F. Brasseur, B. Lethe, F. Jotereau, and T. Boon. 1996. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J. Exp. Med. 183:1173-1183.
8. Van Den Eynde, B.J., B. Gaugler, M. Probst-Kepper, L. Michaux, O. Devuyst, F. Lorge, P. Weynants, and Y. Boon. 1999. A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription. J. Exp. Med. 190:1793-1800.
9. Robbins, P.F., M. El Gamil, Y.F. Li, E.B. Fitzgerald, Y. Kawakami, and S.A. Rosenberg. 1997. The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes. J. Immunol. 159:303-308.
10. Lupetti, R., P. Pisarra, A. Verrecchia, C. Farina, G. Nicolini, A. Anichini, C. Bordignon, M. Sensi, G. Parmiani, and C. Traversari. 1998. Translation of a retained intron in tyrosinase-related protein (TRP)2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage. J. Exp. Med. 188:1005-1016.
11. Wang, R.F., S.L. Johnston, G. Zeng, S.L. Topalian, D.J. Schwartzentruber, and S.A. Rosenberg. 1998. A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames. J. Immunol. 161:3598-3606.
12. Wang, R.F., M.R. Parkhurst, Y. Kawakami, P.F. Robbins, and S.A. Rosenberg. 1996. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J. Exp. Med. 183:1131-1140.
13. Ronsin, C., V. Chung-Scott, I. Poullion, N. Aknouche, C. Gaudin, and F. Triebel. 1999. A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ. J. Immunol. 163:483-490.
14. Aarnoudse, C.A., P.B. van den Doel, B. Heemskerk, and P.I. Schrier. 1999. Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1. Int. J. Cancer. 82:442-448.
15. Pandolfino, M.C., C. Viret, N. Gervois, Y. Guilloux, F. Davodeau, E. Diez, and F. Jotereau. 1992. Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytes. Eur. J. Immunol. 22:1795-1802.
16. Maniatis, T., E.F. Fritsh, and J. Sambrook. 1989. Molecular Cloning. 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 1,659 pp.
17. Brichard, V., A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489-495.
18. Hansen, M.B., S.E. Nielsen, and K. Berg. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods. 119:203-210.
19. Labarriere, N., E. Diez, M.C. Pandolfino, C. Viret, Y. Guilloux, G.S. Le, J.F. Fonteneau, B. Dreno, and F. Jotereau. 1997. Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription. J. Immunol. 158: 1238-1245.
20. Moretti, P., P. Simmons, P. Thomas, D. Haylock, P. Rathjen, M. Vadas, and R. D'Andrea. 1994. Identification of homeobox genes expressed in human haemopoietic progenitor cells. Gene. 144:213-219.
21. Theobald, M., T. Ruppert, U. Kuckelkorn, J. Hernandez, A. Haussler, E.A. Ferreira, U. Liewer, J. Biggs, A.J. Levine, C. Huber, et al. 1998. The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope. J. Exp. Med. 188:1017-1028.
22. Bergmann, C.C., L. Tong, R. Cua, J. Sensintaffar, and S. Stohlman. 1994. Differential effects of flanking residues on presentation of epitopes from chimeric peptides. J. Virol. 68: 5306-5310.
23. Del Val, M., H.J. Schlicht, T. Ruppert, M.J. Reddehase, and U.H. Koszinowski. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell. 66:1145-1153.
24. Eisenlohr, L.C., J.W. Yewdell, and J.R. Bennink. 1992. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:481-487.
25. Niedermann, G., S. Butz, H.G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschutzky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity. 2:289-299.
26. Ossendorp, F., M. Eggers, A. Neisig, T. Ruppert, M. Groettrup, A. Sijts, E. Mengede, P.M. Kloetzel, J. Neefjes, U. Koszinowski, et al. 1996. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity. 5:115-124.
27. Shastri, N., T. Serwold, and F. Gonzalez. 1995. Presentation of endogenous peptide/MHC class 1 complexes is profoundly influenced by specific C-terminal flanking residues. J. Immunol. 155:4339-4346.
28. Yellen-Shaw, A.J., E.J. Wherry, G.C. Dubois, and L.C. Eisenlohr. 1997. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein. J. Immunol. 158:3227-3234.